4-Oxoisotretinoin

CAS No. 71748-58-8

4-Oxoisotretinoin( —— )

Catalog No. M17578 CAS No. 71748-58-8

4-oxo-isotretinoin is the major blood metabolite.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 95 In Stock
5MG 113 In Stock
10MG 159 In Stock
25MG 287 In Stock
50MG 381 In Stock
100MG 557 In Stock
500MG 1197 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-Oxoisotretinoin
  • Note
    Research use only, not for human use.
  • Brief Description
    4-oxo-isotretinoin is the major blood metabolite.
  • Description
    4-oxo-isotretinoin is the major blood metabolite.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Neurokinin Receptor
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    71748-58-8
  • Formula Weight
    314.42
  • Molecular Formula
    C20H26O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=C(C(CCC1=O)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lucio Vilar,et al. The Role of Isotretinoin Therapy for Cushing’s Disease: Results of a Prospective Study. International Journal of Endocrinology Volume 2016, 9.
molnova catalog
related products
  • Neurokinin A(4-10)

    Neurokinin A (4-10) is a tachykinin NK2 receptor agonist. A structure-activity study of the neurokinin A (NKA) fragment NKA(4-10) was performed to investigate the importance of amino acid residues for receptor efficacy, potency and affinity at the NK2 receptor in human colon circular muscle.

  • Vofopitant dihydroch...

    Vofopitant dihydrochloride (GR 205171A) is an orally available, selective tachykinin NK1 receptor antagonist that inhibits [3H]SP binding to NK1 with pKi values of 9.5 and 10.6, respectively.

  • Fezolinetant

    A potent, selective, orally active neurokinin-3 receptor (NK3R) antagonist with pIC50/pKi of 7.7/7.6.